-The Hindu This is hardly a rice ready for cultivation by farmers — it has not even entered the stage of biosafety evaluation by government regulatory institutions. Recently 110 Nobel Laureates issued a strongly worded plea to Greenpeace to “abandon their campaign against [genetically modified organisms] in general and Golden Rice in particular.” This is not the first time notable scientists have waded into the controversy surrounding genetically modified (GM) crops. What...

-Press Statement from Right to Education Forum Lok Sabha has passed today Child Labour (Prohibition and Regulation) Amendment Bill, 2012 and allowed work for children below the age of 14 years in family enterprises is a regressive move. RTE Forum, a coalition of ten thousand grass-root organizations, people’s movement, educationists and teachers organizations, has said that  “Today is black day for the millions of Indian children; they will now be deprived...

-TheWire.in According to the central government’s statement to the Supreme Court last week, a third of the India’s districts are currently facing a severe drought. This means that at least 33 crore Indians are affected by ongoing the crisis. Expressing their deep concern on the issue and the impact it is having on rural populations of the country, and asking that the government take appropriate relief measures immediately, more than 150 academics...

-The Times of India NEW DELHI: The women and child development ministry (WCD) has written to the Rajya Sabha seeking to withdraw its response on marital rape describing it as an "oversight." The fresh response that the ministry is likely to put before Parliament is that the issue is under law commission's consideration. WCD minister Maneka Gandhi's response to a Parliament question in Rajya Sabha terming marital rape as a concept unsuited...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...